In last trading session, Astrana Health Inc (NASDAQ:ASTH) saw 0.34 million shares changing hands with its beta currently measuring 1.05. Company’s recent per share price level of $29.34 trading at $0.15 or 0.50% at ring of the bell on the day assigns it a market valuation of $1.44B. That closing price of ASTH’s stock is at a discount of -115.41% from its 52-week high price of $63.20 and is indicating a premium of 21.2% from its 52-week low price of $23.12. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.42 million shares which gives us an average trading volume of 361.67K if we extend that period to 3-months.
For Astrana Health Inc (ASTH), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.42. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.38 in the current quarter.
Astrana Health Inc (NASDAQ:ASTH) trade information
Upright in the green during last session for gaining 0.50%, in the last five days ASTH remained trading in the red while hitting it’s week-highest on Friday, 03/14/25 when the stock touched $29.34 price level, adding 4.24% to its value on the day. Astrana Health Inc’s shares saw a change of -6.95% in year-to-date performance and have moved -0.14% in past 5-day. Astrana Health Inc (NASDAQ:ASTH) showed a performance of -23.55% in past 30-days. Number of shares sold short was 1.44 million shares which calculate 4.77 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 60 to the stock, which implies a rise of 51.1% to its current value. Analysts have been projecting 50 as a low price target for the stock while placing it at a high target of 70. It follows that stock’s current price would drop -70.42% in reaching the projected high whereas dropping to the targeted low would mean a loss of -70.42% for stock’s current value.
Astrana Health Inc (ASTH) estimates and forecasts
This year revenue growth is estimated to rise 29.55% from the last financial year’s standing.
10 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 628.32M for the same. And 10 analysts are in estimates of company making revenue of 651.39M in the next quarter. Company posted 404.36M and 486.26M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 18.34% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 43.87% while estimates for its earnings growth in next 5 years are of 40.48%.
Astrana Health Inc (NASDAQ:ASTH)’s Major holders
Insiders are in possession of 25.86% of company’s total shares while institution are holding 56.01 percent of that, with stock having share float percentage of 75.55%. Investors also watch the number of corporate investors in a company very closely, which is 56.01% institutions for Astrana Health Inc that are currently holding shares of the company.
On the other hand, iShares Core S&P Smallcap ETF and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jan 31, 2025 , the former fund manager was holding 2.68 shares of worth $78.51 million or 7.48% of the total outstanding shares. The later fund manager was in possession of 1.33 shares on Dec 31, 2024 , making its stake of worth around $38.99 million in the company or a holder of 3.71% of company’s stock.
